BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

252 related articles for article (PubMed ID: 14558388)

  • 21. The importance of total number of sentinel lymph nodes in patients with stage N0 cutaneous melanoma.
    Stewart LE; Tyler DS; Vollmer RT
    Am J Clin Pathol; 2005 Jul; 124(1):77-82. PubMed ID: 16086501
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The role of sentinel lymph node biopsy in the management of thin melanoma.
    Wong SL
    Am J Surg; 2005 Aug; 190(2):196-9. PubMed ID: 16023430
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Sentinel lymph node biopsy for melanoma: prognostic value and disadvantages in 300 patients].
    de Vries M; Jager PL; Suurmeijer AJ; Plukker JT; van Ginkel RJ; Hoekstra HJ
    Ned Tijdschr Geneeskd; 2005 Aug; 149(33):1845-51. PubMed ID: 16128183
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Sentinel node identification by scintigraphic methods in cutaneous melanoma.
    Dias Moreira R; Altino de Almeida S; Maliska Guimarães CM; Resende JF; Gutfilen B; Barbosa da Fonseca LM
    J Exp Clin Cancer Res; 2005 Jun; 24(2):181-5. PubMed ID: 16110749
    [TBL] [Abstract][Full Text] [Related]  

  • 25. In transit/local recurrences in melanoma patients after sentinel node biopsy and therapeutic lymph node dissection.
    Rutkowski P; Nowecki ZI; Zurawski Z; Dziewirski W; Nasierowska-Guttmejer A; Switaj T; Ruka W
    Eur J Cancer; 2006 Jan; 42(2):159-64. PubMed ID: 16324835
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Sentinel lymph node biopsies for cutaneous melanoma.
    Victoria Giblin A; Meirion Thomas J
    Am J Surg Pathol; 2006 Mar; 30(3):418-9; author reply 420-1. PubMed ID: 16538067
    [No Abstract]   [Full Text] [Related]  

  • 27. Sentinel node mapping for melanoma: results of trials and current applications.
    Thompson JF; Shaw HM
    Surg Oncol Clin N Am; 2007 Jan; 16(1):35-54. PubMed ID: 17336235
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Caution with sentinel node biopsy in cutaneous melanoma.
    Thomas JM
    Br J Surg; 2006 Feb; 93(2):129-30. PubMed ID: 16432819
    [No Abstract]   [Full Text] [Related]  

  • 29. Less false-negative sentinel node procedures in melanoma patients with experience and proper collaboration.
    Veenstra HJ; Wouters MW; Kroon BB; Olmos RA; Nieweg OE
    J Surg Oncol; 2011 Oct; 104(5):454-7. PubMed ID: 21538361
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Accuracy of lymphatic mapping and sentinel lymph node biopsy after previous wide local excision in patients with primary melanoma.
    Gannon CJ; Rousseau DL; Ross MI; Johnson MM; Lee JE; Mansfield PF; Cormier JN; Prieto VG; Gershenwald JE
    Cancer; 2006 Dec; 107(11):2647-52. PubMed ID: 17063497
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Re: Selective lymphadenectomy in sentinel node-positive patients may increase the risk of local/in-transit recurrence in malignant melanoma, Thomas and Clark.
    Pawlik TM; Ross MI; Shaw HM; Thompson JF; Gershenwald JE
    Eur J Surg Oncol; 2005 Apr; 31(3):323-4. PubMed ID: 15780572
    [No Abstract]   [Full Text] [Related]  

  • 32. Sentinel lymph node biopsy in melanoma: a micromorphometric study relating to prognosis and completion lymph node dissection.
    Debarbieux S; Duru G; Dalle S; Béatrix O; Balme B; Thomas L
    Br J Dermatol; 2007 Jul; 157(1):58-67. PubMed ID: 17501957
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Analysis of sentinel lymph nodes in melanoma: technique versus rationale.
    Rosai J; Coit DG; Spanknebel K; Klimstra DS
    Am J Surg Pathol; 2006 Mar; 30(3):417-8; author reply 420-1. PubMed ID: 16538066
    [No Abstract]   [Full Text] [Related]  

  • 34. Editorial: sentinel lymph node biopsy.
    Zagarella SS
    Australas J Dermatol; 2010 Feb; 51(1):18-20. PubMed ID: 20148834
    [No Abstract]   [Full Text] [Related]  

  • 35. Prediction of nonsentinel lymph node involvement in patients with a positive sentinel lymph node in malignant melanoma.
    Page AJ; Carlson GW; Delman KA; Murray D; Hestley A; Cohen C
    Am Surg; 2007 Jul; 73(7):674-8; discussion 678-9. PubMed ID: 17674939
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Sentinel lymph node biopsy and completion lymph node dissection for malignant melanoma are not standard of care.
    Coldiron BM; Dinehart S; Rogers HW
    Clin Dermatol; 2009; 27(4):350-4. PubMed ID: 19539161
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Viewpoint of the Dutch Melanoma Working Group regarding sentinel lymph node biopsy: prognostic but not therapeutic implications].
    Kruit WH;
    Ned Tijdschr Geneeskd; 2008 Mar; 152(10):574-6. PubMed ID: 18402325
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Sentinel lymph node biopsy in patients with Stage I/II melanoma: Clinical experience and literature review.
    Gipponi M; Di Somma C; Peressini A; Solari N; Gliori S; Nicolo G; Schenone F; Queirolo P; Sertoli MR; Cafiero F
    J Surg Oncol; 2004 Mar; 85(3):133-40. PubMed ID: 14991885
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Melanoma recurrence patterns after negative sentinel lymphadenectomy.
    Zogakis TG; Essner R; Wang HJ; Turner RR; Takasumi YT; Gaffney RL; Lee JH; Morton DL
    Arch Surg; 2005 Sep; 140(9):865-71; discussion 871-2. PubMed ID: 16172295
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Regarding sentinel node biopsy in the management of melanoma.
    Coldiron B
    Dermatol Surg; 2001 Jan; 27(1):95-7. PubMed ID: 11231262
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.